Error: Could not add to watchlist. X
+ Watchlist

Janus Henderson Global Life Sciences Fund

JNGLX:US
NASDAQ GM
56.89
USD
0.13
0.23%
As of 4/25/2018
Fund Type
Open-End Fund
52Wk Range
50.67 - 60.67
1 Yr Return
12.26%
YTD Return
3.85%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
56.76
52Wk Range
50.67 - 60.67
1 Yr Return
12.67%
YTD Return
3.85%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 04/25/2018)
56.89
Total Assets (b USD) (on 03/30/2018)
3.563
Inception Date
12/31/1998
Last Dividend (on 12/19/2017)
0.204495
Dividend Indicated Gross Yield
0.36%
Fund Managers
ETHAN T LOVELL / ANDY ACKER
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
2.00%
12b-1 Fee
0.00%
Current Mgmt Fee
0.64%
Expense Ratio
0.85%

Top Fund Holdings

Name Position Value % of Fund
AET:US
Aetna Inc
655.17 k 118.19 m 3.31
AZN:LN
AstraZeneca PLC
1.67 m 114.83 m 3.21
LLY:US
Eli Lilly & Co
1.26 m 106.20 m 2.97
SHPG:US
Shire PLC
670.01 k 103.93 m 2.91
SAN:FP
Sanofi
1.18 m 101.99 m 2.85
CELG:US
Celgene Corp
876.86 k 91.51 m 2.56
HUM:US
Humana Inc
328.98 k 81.61 m 2.28
BIIB:US
Biogen Inc
248.69 k 79.23 m 2.22
ANTM:US
Anthem Inc
350.92 k 78.96 m 2.21
NVS:US
Novartis AG
937.26 k 78.69 m 2.20
Profile
Janus Henderson Global Life Sciences Fund seeks long-term growth of capital by investing in equity securities of U.S. and foreign companies, selected for their growth potential, that the manager believes have a life science orientation. The portfolio managers apply a "bottom up" approach in choosing investments.
Address
Janus Funds
151 Detroit Street
Denver, CO 80206-4805
Phone
1-303-333-3863
Website
-